This page lists the SEC filings reported by Avoro Capital Advisors LLC.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-04-23 | Avoro Capital Advisors LLC | Spyre Therapeutics, Inc. | 1,839,138 | 5.1% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | IO Biotech, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | MARINUS PHARMACEUTICALS, INC. | 3,150,000 | 5.8% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | UNITED THERAPEUTICS Corp | 2,858,888 | 6.1% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | CymaBay Therapeutics, Inc. | 16,337,739 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | Xenon Pharmaceuticals Inc. | 5,666,666 | 7.7% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | Mirati Therapeutics, Inc. | 4,886,840 | 7.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | Monte Rosa Therapeutics, Inc. | 4,535,000 | 9.1% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | Kymera Therapeutics, Inc. | 3,775,000 | 6.8% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | Ascendis Pharma A/S | 3,755,555 | 6.5% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | PMV Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | Mersana Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | MADRIGAL PHARMACEUTICALS, INC. | 2,288,888 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | AMICUS THERAPEUTICS, INC. | 27,400,000 | 9.3% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | Apellis Pharmaceuticals, Inc. | 13,411,111 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | Krystal Biotech, Inc. | 2,565,555 | 9.1% | EDGAR |
| SC 13G | 2024-02-14 | Avoro Capital Advisors LLC | BIOCRYST PHARMACEUTICALS INC | 13,050,000 | 6.4% | EDGAR |
| SC 13G | 2024-02-14 | Avoro Capital Advisors LLC | Structure Therapeutics Inc. | 6,999,999 | 5.0% | EDGAR |
| SC 13G | 2024-02-14 | Avoro Capital Advisors LLC | Spyre Therapeutics, Inc. | 2,125,597 | 5.9% | EDGAR |
| SC 13G | 2024-02-14 | Avoro Capital Advisors LLC | Verrica Pharmaceuticals Inc. | 6,583,332 | 10.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.